Cerus reported $1.01B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Antares Pharma ATRS:US $ 735.96M 42.2M
Atrion ATRI:US 1.13B 37.25M
Cerulean Pharma CERU:US $ 93.27M 13.31M
Cerus CERS:US $ 1.01B 621.02K
Cytori Therapeutics CYTX:US $ 26.2M 1.77M
GRIFOLS GRF:SM 13.6B 337.76M
Haemonetics HAE:US $ 3.4B 2.25B
Meridian Bioscience VIVO:US $ 961.06M 171.5M
Neogen NEOG:US $ 4.95B 191.65M
Nuvasive NUVA:US $ 3.5B 132.36M
Orasure Technologies OSUR:US $ 729.67M 118.11M
Quidel QDEL:US $ 5.45B 9.11M
Rockwell Medical RMTI:US $ 85.38M 23.18M
Sientra SIEN:US $ 457.86M 39.11M
Staar Surgical STAA:US $ 7.15B 2.24B
Terumo 4543:JP 3419.36B 382.04B
Utah Medical Products UTMD:US $ 315.72M 24.74M